Aristotle University Of Thessaloniki (AUTH)
Διερεύνηση του ρόλου της βασπίνης στην παθογένεια του σακχαρώδη διαβήτη κύησης
Abstract
dc:descriptionPregnancy is characterized by a gradual increase in insulin resistance followed by a compensative increase in insulin secretion in order to maintain euglycaemia (147). Inability of the body to compensate sufficiently this increase of insulin resistance results in the development of gestational diabetes (GDM). This disorder is typically restored to pre-pregnancy state postpartum. The adipokine vaspin is considered to improve insulin sensitivity, therefore, it might be implicated in endogenous glucose regulation in pregnancy, while alterations of its levels could be related to emerge of GDM.In the present study, we aimed to evaluate the alterations in serum vaspin levels throughout pregnancy and postpartum in women with and without GDM, as well as their correlations with known markers of insulin resistance and lipids, in an attempt to investigate the role of vaspin in both abnormal and normal glucose metabolism during pregnancy. Furthermore, we evaluated women with GDM treated with diet only compared to those treated with diet plus insulin in an attempt to clarify the effect of the degree of glucose metabolism deregulation or the exogenous administration of insulin on serum vaspin levels.Eighty-eight pregnant women were studied. Half of them (n=44) had been diagnosed as having GDM while the remaining women (n=44) had normal glucose tolerance. Women with GDM were further divided into two subgroups: those managed throughout pregnancy with diet alone (n=20) and those to whom additional insulin therapy was required (n=24). Serum vaspin, insulin, glucose and lipids were measured, and the insulin sensitivity index QUICKI and the insulin resistance index HOMA-IR were calculated at three time-points: at the 2nd and 3rd trimester of pregnancy and postpartum.Circulating vaspin levels decreased significantly postpartum in all groups of women, but did not differ between GDM or GDM subgroups and controls in any time point. At the 3rd trimester of pregnancy vaspin was positively correlated to insulin, HOMA-IR and triglycerides and negatively correlated to QUICKI in the GDM women, but not in the controls. These correlations were not observed at the 2nd trimester or postpartum. Vaspin, in contrast to HOMA-IR, could not independently predict GDM in binary logistic regression. In the subgroup of women with GDM where insulin treatment was required, it did not affect vaspin levels.Our data suggest that during pregnancy vaspin levels gradually decrease from the 2nd trimester to postpartum; however, decreases are similar between women with or without GDM as well as between women with GDM managed with diet alone or with comcomitant insulin administration. Serum vaspin levels at the 2nd trimester could not independently predict the risk for GDM. Finally, in women with GDM circulating vaspin leves are not affected by the degree of glucose metabolism deregulation or the exogenous administration of insulin, as evident by the lack of differences among our two subgroups of patients with GDM.During pregnancy, women with GDM had higher glucose, triglycerides and insulin levels, higher HOMA-IR and lower QUICKI compared to normal pregnancy. These differences remained postpartum, suggesting that the defect in insulin sensitivity and glucose metabolism that drives to the development of GDM is present to some degree after delivery.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gkiomisi, Athina
- Γκιομίση, Αθηνά
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35756